Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease
Parkinsonism & Related Disorders. Bd. 50. Elsevier BV 2018 S. 104 - 107
Erscheinungsjahr: 2018
ISBN/ISSN: 1353-8020
Publikationstyp: Zeitschriftenaufsatz
Sprache: Englisch
Doi/URN: 10.1016/j.parkreldis.2018.02.022
Geprüft | Bibliothek |
Inhaltszusammenfassung
Background/Objective Intestinal inflammation and increased intestinal permeability (both possibly fueled by dysbiosis) have been suggested to be implicated in the multifactorial pathogenesis of Parkinson's disease (PD). The objective of the current study was to investigate whether fecal markers of inflammation and impaired intestinal barrier function corroborate this pathogenic aspect of PD. Methods In a case-control study, we quantitatively analyzed established fecal markers of intest...Background/Objective Intestinal inflammation and increased intestinal permeability (both possibly fueled by dysbiosis) have been suggested to be implicated in the multifactorial pathogenesis of Parkinson's disease (PD). The objective of the current study was to investigate whether fecal markers of inflammation and impaired intestinal barrier function corroborate this pathogenic aspect of PD. Methods In a case-control study, we quantitatively analyzed established fecal markers of intestinal inflammation (calprotectin and lactoferrin) and fecal markers of intestinal permeability (alpha-1-antitrypsin and zonulin) in PD patients (n = 34) and controls (n = 28, group-matched for age) by enzyme-linked immunosorbent assay. The study design controlled for potential confounding factors.» weiterlesen» einklappen
Autoren
Klassifikation
DFG Fachgebiet:
Medizin
DDC Sachgruppe:
Medizin